Ratio Therapeutics Inc. (Ratio), a pharmaceutical company employing innovative technologies to develop best-in-class radiopharmaceuticals for cancer treatment and monitoring, today announced the ...

Texas Oncology broke ground on a $120 million flagship facility in Plano. It will be the city’s first full-service Texas Oncology center. Texas Oncology has four locations, which will be consolidated ...

Teaching Communication Skills and Developing Comfort With Difficult Conversations: A Combined Palliative Care-Oncology Simulation Session for Hematology/Oncology Fellows A systematic, modified Delphi ...

Cancer remains a leading cause of global morbidity and mortality, and conventional therapeutic strategies are often limited by poor tumor selectivity, ...

What work are you leading to help address the challenges of bringing clinical trials to patients and to help advance drug development? We're exclusively focused on cancer clinical trials in the ...

October is a pivotal month for the oncology community, with ESMO and other key oncology medical congresses poised to deliver defining moments for the field. As Astellas prepares to share new insights ...

The first and largest dataset of genomic structure variations specific to childhood cancers was published today by scientists from St. Jude Children's Research Hospital and the National Cancer ...

Antibody-drug conjugates (ADCs) have revolutionized the oncology field, offering targeted cancer treatments that improve efficacy without adversely affecting healthy cells. 1 ADCs’ potential extends ...

Good day, everyone, and welcome to Pfizer Pflash, a spotlight on the PD-1 VEGF bispecific PF-4404 clinical development strategy. Today's call is being recorded. At this time, I would like to turn the ...

A new preclinical study in mice shows that precancerous cells in the pancreas can be eliminated before they have the chance to become tumors. Using an experimental therapy to target microscopic ...

As the medical school landscape shifts in response to federal pressures and new demands in the healthcare space — such as technological advancements, AI and drug innovations — new physicians may be ...